News
New cost-cutting Medicaid rule could save US billions
A newly proposed cost-cutting rule implemented into the US Medicaid programme could save the country up to $17.7bn over five years, say US health...
News
Shire partners Sangamo to develop hemophilia treatments
Shire has signed a collaboration and license agreement with Sangamo Bioscience to develop therapeutics for hemophilia and other monogenic diseases using Sangamo's zinc finger...
News
NanoViricides files FluCide pre-IND to FDA
NanoViricides has submitted a pre- Investigational New Drug (IND) briefing document of its anti-influenza drug candidate, FluCide to the US Food and Drug Administration...
News
Orexo announces termination of OX-CLI and OX-ESI programs
Orexo and Janssen Pharmaceuticals, formerly Ortho-McNeil-Janssen Pharmaceuticals, and Janssen Pharmaceutica, have terminated their research collaboration and license agreement regarding the OX-CLI and OX-ESI programs....
News
Precision receives US patent related to engineered meganucleases
Precision BioSciences has received US patent which covers claims related to methods of cleaving a target DNA site in a cell using an engineered...
News
Vanda reports positive data of tasimelteon in Non-24-Hour Disorder
Vanda Pharmaceuticals' tasimelteon has shown the ability to reset the body clock and to align it to a constant 24-hour day in patients suffering...
News
Prosensa secures financing to develop RNA-modulating therapeutics
Dutch-based biopharmaceutical company, Prosensa has raised €23m in new equity financing to advance its portfolio of RNA-modulating therapeutics for the treatment of rare diseases,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.